138 related articles for article (PubMed ID: 25998323)
1. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment.
Schoot RA; Slater O; Ronckers CM; Zwinderman AH; Balm AJ; Hartley B; van den Brekel MW; Gupta S; Saeed P; Gajdosova E; Pieters BR; Gaze MN; Mandeville HC; Fajardo RD; Chang YC; Gains JE; Strackee SD; Dunaway D; Abela C; Mason C; Smeele LE; Chisholm JC; Levitt GA; Kremer LC; Grootenhuis MA; Maurice-Stam H; Stiller CA; Hammond P; Caron HN; Merks JH
Eur J Cancer; 2015 Jul; 51(11):1424-34. PubMed ID: 25998323
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
3. Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.
Schoot RA; Theunissen EA; Slater O; Lopez-Yurda M; Zuur CL; Gaze MN; Chang YC; Mandeville HC; Gains JE; Rajput K; Pieters BR; Davila Fajardo R; Talwar R; Caron HN; Balm AJ; Dreschler WA; Merks JH
Clin Otolaryngol; 2016 Jun; 41(3):276-83. PubMed ID: 26293165
[TBL] [Abstract][Full Text] [Related]
4. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
[TBL] [Abstract][Full Text] [Related]
5. A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol.
Buwalda J; Schouwenburg PF; Blank LE; Merks JH; Copper MP; Strackee SD; Voûte PA; Caron HN
Eur J Cancer; 2003 Jul; 39(11):1594-602. PubMed ID: 12855267
[TBL] [Abstract][Full Text] [Related]
6. Facial asymmetry in head and neck rhabdomyosarcoma survivors.
Schoot RA; Hol MLF; Merks JHM; Suttie M; Slater O; van Lennep M; Hopman SMJ; Dunaway D; Syme-Grant J; Smeele LE; Zwinderman KH; Caron HN; Hammond P
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423221
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Vaarwerk B; Schoot RA; Maurice-Stam H; Slater O; Hartley B; Saeed P; Gajdosova E; van den Brekel MW; Balm AJM; Hol MLF; van Jaarsveld S; Kremer LCM; Ronckers CM; Mandeville HC; Pieters BR; Gaze MN; Davila Fajardo R; Strackee SD; Dunaway D; Smeele LE; Chisholm JC; Caron HN; Grootenhuis MA; Merks JHM
Pediatr Blood Cancer; 2019 Feb; 66(2):e27498. PubMed ID: 30318743
[TBL] [Abstract][Full Text] [Related]
8. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children.
Buwalda J; Blank LE; Schouwenburg PF; Copper MP; Strackee SD; Voûte PA; Merks JH; Caron HN
Eur J Surg Oncol; 2004 Oct; 30(8):884-92. PubMed ID: 15336736
[TBL] [Abstract][Full Text] [Related]
9. The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view.
Blank LE; Koedooder K; Pieters BR; van der Grient HN; van de Kar M; Buwalda J; Balm AJ; Merks JH; Strackee SD; Freling NJ; Koning CC
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1555-62. PubMed ID: 19250759
[TBL] [Abstract][Full Text] [Related]
10. AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns.
Buwalda J; Freling NJ; Blank LE; Balm AJ; Bras J; Voûte PA; Caron HN; Schouwenburg PF; Merks JH
Head Neck; 2005 May; 27(5):390-6. PubMed ID: 15825203
[TBL] [Abstract][Full Text] [Related]
11. New combined treatment of surgery, radiotherapy, and reconstruction in head and neck rhabdomyosarcoma in children: the AMORE protocol.
Schouwenburg PF; Kupperman D; Bakker FP; Blank LE; de Boer HB; Voûte TA
Head Neck; 1998 Jul; 20(4):283-92. PubMed ID: 9588699
[TBL] [Abstract][Full Text] [Related]
12. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
Hol MLF; Indelicato DJ; Slater O; Kolb F; Hewitt RJ; Ong J; Becking AG; Gains J; Bradley J; Sandler E; Gaze MN; Pieters B; Mandeville H; Fajardo RD; Schoot R; Merks JHM; Hammond P; Smeele LE; Suttie M
Pediatr Blood Cancer; 2023 Aug; 70(8):e30412. PubMed ID: 37249325
[TBL] [Abstract][Full Text] [Related]
13. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors.
van Dijk IW; Cardous-Ubbink MC; van der Pal HJ; Heinen RC; van Leeuwen FE; Oldenburger F; van Os RM; Ronckers CM; Schouten-van Meeteren AY; Caron HN; Koning CC; Kremer LC
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):768-75. PubMed ID: 22954771
[TBL] [Abstract][Full Text] [Related]
14. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial module.
Morfouace M; Hol MLF; Schoot RA; Slater O; Indelicato DJ; Kolb F; Smeele LE; Merks JHM; Rae C; Maurice-Stam H; Klassen AF; Grootenhuis MA
Cancer Med; 2023 Feb; 12(4):4739-4750. PubMed ID: 36208014
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of late adverse events in long-term wilms' tumor survivors.
van Dijk IW; Oldenburger F; Cardous-Ubbink MC; Geenen MM; Heinen RC; de Kraker J; van Leeuwen FE; van der Pal HJ; Caron HN; Koning CC; Kremer LC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):370-8. PubMed ID: 20137867
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
